Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 22
Phase 31

Trial Status

Completed3

Role Distribution

Principal Investigator2
Other Roles1
PI Rate67%

Activity Timeline

Clinical Trials (3)

NCT00117572Phase 3Completed
Docetaxel Based Chemotherapy Plus or Minus Induction Chemotherapy to Decrease Events in Head and Neck Cancer (DeCIDE)
Cancer of the LarynxCancer of the Nasal CavityCancer of the Oral Cavity+2 more
Principalinvestigator
NCT01133665Phase 2Completed
Cetuximab and Lenalidomide in Head and Neck
Squamous Cell Carcinoma
Studychair

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT00117572Phase 3PrincipalInvestigator

Docetaxel Based Chemotherapy Plus or Minus Induction Chemotherapy to Decrease Events in Head and Neck Cancer (DeCIDE)

Cancer of the LarynxCancer of the Nasal CavityCancer of the Oral Cavity+2 more
Completed
NCT00203905Phase 2PrincipalInvestigator

A Study of Chemoradiotherapy for Intermediate Stage/Selected Stage IV Cancers of the Head and Neck

Head and Neck Cancer
Completed
NCT01133665Phase 2StudyChair

Cetuximab and Lenalidomide in Head and Neck

Squamous Cell Carcinoma
Completed

All 3 trials loaded